Your browser doesn't support javascript.
loading
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers, Christopher J; Harman, Robert J; Bunnell, Bruce A; Schreiber, Martin A; Xiang, Charlie; Wang, Fu-Sheng; Santidrian, Antonio F; Minev, Boris R.
Affiliation
  • Rogers CJ; Personalized Stem Cells, Inc, Poway, CA, USA. crogers@pscells.com.
  • Harman RJ; Personalized Stem Cells, Inc, Poway, CA, USA.
  • Bunnell BA; Center for Stem Cell Research and Regenerative Medicine, Tulane University School of Medicine, New Orleans, LA, USA.
  • Schreiber MA; Department of Surgery, Oregon Health and Science University, Portland, OR, USA.
  • Xiang C; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.
  • Wang FS; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center, Beijing, 100039, China.
  • Santidrian AF; Calidi Biotherapeutics, Inc., San Diego, CA, USA.
  • Minev BR; Calidi Biotherapeutics, Inc., San Diego, CA, USA.
J Transl Med ; 18(1): 203, 2020 05 18.
Article in En | MEDLINE | ID: mdl-32423449

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells / Betacoronavirus Limits: Animals / Humans Language: En Journal: J Transl Med Year: 2020 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Mesenchymal Stem Cell Transplantation / Mesenchymal Stem Cells / Betacoronavirus Limits: Animals / Humans Language: En Journal: J Transl Med Year: 2020 Document type: Article Affiliation country: United States